These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34445620)

  • 21. Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells.
    Du Y; Fu X; Li H; Chen B; Guo Y; Su G; Zhang H; Ning F; Lin Y; Mei W; Chen T
    ChemMedChem; 2014 Apr; 9(4):714-8. PubMed ID: 24403015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymer "ruthenium-cyclopentadienyl" conjugates - New emerging anti-cancer drugs.
    Moreira T; Francisco R; Comsa E; Duban-Deweer S; Labas V; Teixeira-Gomes AP; Combes-Soia L; Marques F; Matos A; Favrelle A; Rousseau C; Zinck P; Falson P; Garcia MH; Preto A; Valente A
    Eur J Med Chem; 2019 Apr; 168():373-384. PubMed ID: 30826512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid.
    Graminha AE; Honorato J; Dulcey LL; Godoy LR; Barbosa MF; Cominetti MR; Menezes AC; Batista AA
    J Inorg Biochem; 2020 May; 206():111021. PubMed ID: 32163810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor Activity of Pt(II), Ru(III) and Cu(II) Complexes.
    Gałczyńska K; Drulis-Kawa Z; Arabski M
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32751963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
    PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 227():117534. PubMed ID: 31685424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of in vitro absorption in Caco-2 monolayers of anticancer Ru(II)-based complexes acting as dual human topoisomerase and PARP inhibitors.
    de Camargo MS; De Grandis RA; da Silva MM; da Silva PB; Santoni MM; Eismann CE; Menegário AA; Cominetti MR; Zanelli CF; Pavan FR; Batista AA
    Biometals; 2019 Feb; 32(1):89-100. PubMed ID: 30506342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells.
    Pracharova J; Novohradsky V; Kostrhunova H; Štarha P; Trávníček Z; Kasparkova J; Brabec V
    Dalton Trans; 2018 Sep; 47(35):12197-12208. PubMed ID: 30112527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copper (II) complexes possessing alkyl-substituted polypyridyl ligands: Structural characterization and in vitro antitumor activity.
    Angel NR; Khatib RM; Jenkins J; Smith M; Rubalcava JM; Le BK; Lussier D; Chen ZG; Tham FS; Wilson EH; Eichler JF
    J Inorg Biochem; 2017 Jan; 166():12-25. PubMed ID: 27815978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates.
    Notaro A; Gasser G
    Chem Soc Rev; 2017 Nov; 46(23):7317-7337. PubMed ID: 29027562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes.
    Sathiya Kamatchi T; Mohamed Subarkhan MK; Ramesh R; Wang H; Małecki JG
    Dalton Trans; 2020 Aug; 49(32):11385-11395. PubMed ID: 32776042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ruthenium(II)-Arene Thiocarboxylates: Identification of a Stable Dimer Selectively Cytotoxic to Invasive Breast Cancer Cells.
    Stephens LJ; Levina A; Trinh I; Blair VL; Werrett MV; Lay PA; Andrews PC
    Chembiochem; 2020 Apr; 21(8):1188-1200. PubMed ID: 31701616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of
    Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
    Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic
    Acharya S; Maji M; Chakraborty MP; Bhattacharya I; Das R; Gupta A; Mukherjee A
    Inorg Chem; 2021 Mar; 60(5):3418-3430. PubMed ID: 33554592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, Characterization, and Inducing Tumor Cell Apoptosis of Two Ru(II) Complexes Containing Guanidinium as Ligands.
    Sun J; Chen WX; Song XD; He SF; Chen JX; Mei J; Zhu XX; Wu T
    Anticancer Agents Med Chem; 2018; 18(1):110-120. PubMed ID: 28425859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic and anticancer properties of new ruthenium polypyridyl complexes with different lipophilicities.
    Florence Tikum A; Jeon YJ; Lee JH; Park MH; Bae IY; Kim SH; Lee HJ; Kim J
    J Inorg Biochem; 2018 Mar; 180():204-210. PubMed ID: 29329027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lead to hit ruthenium-cyclopentadienyl anticancer compounds: Cytotoxicity against breast cancer cells, metabolic stability and metabolite profiling.
    Maximiano I; Henriques C; Teixeira RG; Marques F; Valente A; Antunes AMM
    J Inorg Biochem; 2024 Feb; 251():112436. PubMed ID: 38016328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, DNA Cleavage Activity, Cytotoxicity, Acetylcholinesterase Inhibition, and Acute Murine Toxicity of Redox-Active Ruthenium(II) Polypyridyl Complexes.
    Alatrash N; Narh ES; Yadav A; Kim MJ; Janaratne T; Gabriel J; MacDonnell FM
    ChemMedChem; 2017 Jul; 12(13):1055-1069. PubMed ID: 28605571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polypyridyl Ruthenium(II) complex-induced mitochondrial membrane potential dissipation activates DNA damage-mediated apoptosis to inhibit liver cancer.
    Li Y; Wu Q; Yu G; Li L; Zhao X; Huang X; Mei W
    Eur J Med Chem; 2019 Feb; 164():282-291. PubMed ID: 30599417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.
    Arandjelovic SS; Bjelogrlic KS; Malesevic NN; Tesic LjZ; Radulovic SS
    J BUON; 2009; 14(2):271-9. PubMed ID: 19650178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.